HYPEROXIA AND OXYGEN THERAPY IN EMERGENCY CONDITIONS: DOES MORE OXYGEN ALWAYS MEAN BETTER OUTCOMES? A NARRATIVE REVIEW

Authors

DOI:

https://doi.org/10.31435/ijitss.3(51).2026.6166

Keywords:

Hyperoxia, Oxygen Therapy, Emergency Medicine, Critical Care, Oxidative Stress, Resuscitation, Oxygen Toxicity

Abstract

Oxygen therapy remains one of the most frequently administered interventions in emergency and critical care medicine. Traditionally, supplemental oxygen has been perceived as a harmless and universally beneficial treatment for patients experiencing acute illness, trauma, or cardiorespiratory compromise. However, growing evidence accumulated over the last two decades suggests that excessive oxygen administration may be associated with adverse physiological effects and worse clinical outcomes. Hyperoxia, defined as an abnormally elevated partial pressure of oxygen in arterial blood, has emerged as an important and potentially modifiable factor in the management of critically ill patients. Numerous observational studies, randomized controlled trials, and meta-analyses have demonstrated associations between hyperoxia and increased mortality, neurological injury, oxidative stress, vasoconstriction, and organ dysfunction.

The purpose of this review is to summarize current evidence regarding the pathophysiology of hyperoxia and its clinical implications in emergency medicine and critical care. Particular emphasis is placed on acute conditions frequently encountered in emergency departments and intensive care units, including cardiac arrest, acute coronary syndromes, stroke, traumatic brain injury, sepsis, and acute respiratory failure. The review also discusses current guideline recommendations and highlights areas requiring further investigation. Contemporary evidence suggests that oxygen should be regarded as a drug requiring individualized dosing, monitoring, and titration rather than a universally beneficial intervention. Avoidance of both hypoxemia and hyperoxemia appears crucial for optimizing patient outcomes.

References

Asfar, P., et al. (2017). Hyperoxia and hypertonic saline in patients with septic shock (HYPERS2S). Lancet Respiratory Medicine, 5(3), 180–190. https://doi.org/10.1016/S2213-2600(17)30046-2

Auten, R. L., & Davis, J. M. (2009). Oxygen toxicity and reactive oxygen species. Seminars in Fetal and Neonatal Medicine, 14(6), 357–366. https://doi.org/10.1016/j.siny.2009.08.003

Barrot, L., et al. (2020). Liberal or conservative oxygen therapy for acute respiratory distress syndrome (LOCO₂). JAMA, 323(11), 999–1008. https://doi.org/10.1001/jama.2020.1021

Beasley, R., Chien, J., Douglas, J., et al. (2015). Thoracic Society oxygen guidelines. Respirology, 20(8), 1182–1191. https://doi.org/10.1111/resp.12620

Bellomo, R., Bailey, M., Eastwood, G., et al. (2011). Arterial hyperoxia and mortality. Critical Care, 15(2), R90. https://doi.org/10.1186/cc10073

Chu, D. K., Kim, L. H. Y., Young, P. J., et al. (2018). Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy. Lancet, 391(10131), 1693–1705. https://doi.org/10.1016/S0140-6736(18)30479-3

Davis, D. P., Meade, W., Sise, M. J., et al. (2009). Both hypoxemia and extreme hyperoxemia may be detrimental after traumatic brain injury. Journal of Neurotrauma, 26(12), 2217–2223. https://doi.org/10.1089/neu.2009.0940

de Jonge, E., Peelen, L., Keijzers, P. J., et al. (2008). Association between administered oxygen and mortality in critically ill patients. Critical Care, 12(6), R156. https://doi.org/10.1186/cc7150

Farquhar, H., Weatherall, M., Wijesinghe, M., et al. (2009). Systematic review of oxygen effects on coronary blood flow. Heart, 95(3), 198–202. https://doi.org/10.1136/hrt.2008.14323

Girardis, M., Busani, S., Damiani, E., et al. (2016). Oxygen-ICU trial. JAMA, 316(15), 1583–1589. https://doi.org/10.1001/jama.2016.11993

Helmerhorst, H. J. F., Roos-Blom, M. J., van Westerloo, D. J., et al. (2015). Associations of arterial hyperoxia with outcome. Critical Care Medicine, 43(7), 1508–1519. https://doi.org/10.1097/CCM.0000000000000998

Hofmann, R., James, S. K., Jernberg, T., et al. (2017). DETO2X-AMI trial. New England Journal of Medicine, 377(13), 1240–1249. https://doi.org/10.1056/NEJMoa1706222

Ibanez, B., James, S., Agewall, S., et al. (2018). ESC STEMI guidelines. European Heart Journal, 39(2), 119–177. https://doi.org/10.1093/eurheartj/ehx393

Kallet, R. H., & Matthay, M. A. (2013). Hyperoxic acute lung injury. Respiratory Care, 58(1), 123–141. https://doi.org/10.4187/respcare.01963

Kilgannon, J. H., Jones, A. E., Shapiro, N. I., et al. (2010). Hyperoxia after resuscitation. JAMA, 303(21), 2165–2171. https://doi.org/10.1001/jama.2010.707

Lumb, A. B. (2020). Nunn's Applied Respiratory Physiology (9th ed.). https://doi.org/10.1016/C2017-0-02479-7

Mackle, D., Bellomo, R., Bailey, M., et al. (2020). ICU-ROX trial. New England Journal of Medicine, 382(11), 989–998. https://doi.org/10.1056/NEJMoa1903297

Mach, W. J., Thimmesch, A. R., Pierce, J. T., et al. (2011). Consequences of hyperoxia and oxidative stress. Physiology, 26(2), 116–126. https://doi.org/10.1152/physiol.00046.2010

Møller, J. E., et al. (2022). BOX trial. New England Journal of Medicine, 387(15), 1465–1476. https://doi.org/10.1056/NEJMoa2208687

O'Driscoll, B. R., Howard, L. S., Earis, J., et al. (2017). BTS guideline for oxygen use. Thorax, 72(Suppl 1), ii1–ii90. https://doi.org/10.1136/thoraxjnl-2016-209729

Perkins, G. D., Graesner, J. T., Semeraro, F., et al. (2021). ERC Guidelines 2021. Resuscitation, 161, 1–60. https://doi.org/10.1016/j.resuscitation.2021.02.003

Powers, W. J., Rabinstein, A. A., Ackerson, T., et al. (2019). Stroke guidelines. Stroke, 50(12), e344–e418. https://doi.org/10.1161/STR.0000000000000211

Roberts, B. W., Kilgannon, J. H., Hunter, B. R., et al. (2018). Hyperoxia and post-cardiac arrest outcomes. Circulation, 137(20), 2114–2124. https://doi.org/10.1161/CIRCULATIONAHA.117.032979

Roffe, C., Nevatte, T., Sim, J., et al. (2017). Stroke Oxygen Study. JAMA, 318(12), 1125–1135. https://doi.org/10.1001/jama.2017.11463

Schjørring, O. L., Klitgaard, T. L., Perner, A., et al. (2021). HOT-ICU trial. New England Journal of Medicine, 384(14), 1301–1311. https://doi.org/10.1056/NEJMoa2032510

Singhal, A. B. (2007). Oxygen therapy in stroke. Stroke, 38(2), 1118–1120. https://doi.org/10.1161/01.STR.0000258114.36817.2e

Stub, D., Smith, K., Bernard, S., et al. (2015). AVOID trial. Circulation, 131(24), 2143–2150. https://doi.org/10.1161/CIRCULATIONAHA.114.014494

Vincent, J. L., & De Backer, D. (2013). Oxygen transport. New England Journal of Medicine, 369(18), 1726–1734. https://doi.org/10.1056/NEJMra1208943

West, J. B. (2012). Respiratory physiology. American Journal of Respiratory and Critical Care Medicine, 186(10), 1039. https://doi.org/10.1164/rccm.186.10.1039

Young, P., Mackle, D., Bellomo, R., et al. (2020). Conservative oxygen therapy in hypoxic ischemic encephalopathy. Intensive Care Medicine, 46(12), 2411–2422. https://doi.org/10.1007/s00134-020-06196-y

Young, P., Mackle, D., Bellomo, R., et al. (2020). Conservative oxygen therapy in sepsis. Intensive Care Medicine, 46(1), 17–26. https://doi.org/10.1007/s00134-019-05857-x

Angus, D. C. (2020). Oxygen therapy for the critically ill. New England Journal of Medicine, 382(11), 1054–1056. https://doi.org/10.1056/NEJMe2000800

Damiani, E., Adrario, E., Girardis, M., et al. (2014). Arterial hyperoxia and mortality in ICU patients: systematic review. Critical Care, 18(6), 711. https://doi.org/10.1186/s13054-014-0711-x

Eastwood, G., Bellomo, R., Bailey, M., et al. (2012). Arterial oxygen tension and mortality. Critical Care, 16(3), R90. https://doi.org/10.1186/cc11317

Palmer, E., Post, B., Klapaukh, R., et al. (2019). Oxygen therapy and clinical outcomes. Anaesthesia, 74(10), 1305–1314. https://doi.org/10.1111/anae.14770

Suzuki, S., Eastwood, G., Peck, L., et al. (2013). Current oxygen management in ICU. Critical Care, 17(6), R304. https://doi.org/10.1186/cc13144

Wettstein, R. B., Shelledy, D. C., & Peters, J. I. (2005). Hyperoxia and oxygen toxicity. Respiratory Care, 50(1), 84–98. https://doi.org/10.4187/respcare.50.1.84

Helmerhorst, H. J. F., Schultz, M. J., van der Voort, P. H. J., et al. (2017). Bench-to-bedside review of hyperoxia. Intensive Care Medicine Experimental, 5(1), 1–12. https://doi.org/10.1186/s40635-017-0145-5

Beasley, R., Aldington, S., Robinson, G., et al. (2007). Is oxygen a drug? Respiratory Medicine, 101(4), 641–642. https://doi.org/10.1016/j.rmed.2006.09.004

Wijesinghe, M., Perrin, K., Ranchord, A., et al. (2009). Routine oxygen therapy in myocardial infarction. Heart, 95(3), 198–202. https://doi.org/10.1136/hrt.2008.143230

Downloads

Published

2026-09-04

How to Cite

Myszak, D., Strzykała, A. ., Lewandowski, J. ., Szlegiel, I., & Gwiaździńska, O. (2026). HYPEROXIA AND OXYGEN THERAPY IN EMERGENCY CONDITIONS: DOES MORE OXYGEN ALWAYS MEAN BETTER OUTCOMES? A NARRATIVE REVIEW. International Journal of Innovative Technologies in Social Science, 3(3(51). https://doi.org/10.31435/ijitss.3(51).2026.6166

Most read articles by the same author(s)